Bicycle Therapeutics plc (BCYC)
NASDAQ·Healthcare·Biotechnology
$3.79
+3.84%
Mkt Cap $372.77M
Analyst Ratings
No recent rating data.
Price Target (15 analysts)
$10.67
Range $8.00 – $12.00
Implied Upside
+181.5%
Consensus $10.67 vs current $3.79
NASDAQ·Healthcare·Biotechnology
$3.79
+3.84%
Mkt Cap $372.77M
No recent rating data.
Price Target (15 analysts)
$10.67
Range $8.00 – $12.00
+181.5%
Consensus $10.67 vs current $3.79